(Q27681399)

English

The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cancer (English)
0 references
Richard T Lewis
0 references
Christiane M Bode
0 references
Deborah M Choquette
0 references
Michele Potashman
0 references
Karina Romero
0 references
John C Stellwagen
0 references
Yohannes Teffera
0 references
Earl Moore
0 references
Douglas A Whittington
0 references
Hao Chen
0 references
Linda F Epstein
0 references
Renee Emkey
0 references
Paul S Andrews
0 references
Violeta L Yu
0 references
Douglas C Saffran
0 references
Man Xu
0 references
Allison Drew
0 references
Patricia Merkel
0 references
Steven Szilvassy
0 references
Rachael L Brake
0 references
26 July 2012
0 references
55
0 references
14
0 references
6523-40
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit